×
About 753 results

ALLMedicine™ Alopecia Areata Center

Research & Reviews  255 results

A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP...
https://doi.org/10.1016/j.intimp.2021.107971
International Immunopharmacology; Ghandi N, Daneshmand R et. al.

Jul 24th, 2021 - Alopecia areata (AA) is a chronic autoimmune disorder. Finding the best treatment regimen for it remains a challenge. Currently, one of the best documented treatment modalities for AA is topical immunotherapy. To evaluate the safety and efficacy o...

Is Heritability of Alopecia Areata Sex-Specific? A Nationwide Population-Based Cohort S...
https://doi.org/10.1111/ced.14836
Clinical and Experimental Dermatology; Wong CK, Chen YL et. al.

Jul 9th, 2021 - Previous studies have demonstrated the heritability of alopecia areata (AA). However, whether the heritability of AA is sex-specific has not been examined. A nationwide population-based retrospective cohort study was performed using the Taiwan Mat...

Superficial cryotherapy using dimethyl ether and propane mixture versus microneedling i...
https://doi.org/10.1111/dth.15044
Dermatologic Therapy; Aboeldahab S, Nada EEA et. al.

Jun 28th, 2021 - To verify and compare the therapeutic efficacy and safety of superficial cryotherapy using dimethyl ether and propane (DMEP) mixture vs. microneedling in the treatment of mild scalp alopecia areata (AA). In a prospective randomized single-blinded ...

see more →

Clinicaltrials.gov  16 results

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
https://clinicaltrials.gov/ct2/show/NCT03359356

Apr 24th, 2020 - The purpose of this study is to assess whether dupilumab can be a helpful treatment for alopecia areata. This is a randomized, double-blind, placebo-controlled pilot study of a total of 54 subjects with moderate to severe alopecia areata involving...

DPCP for the Treatment of Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT03651752

Feb 5th, 2020 - This is an open labeled study to determine the response and characteristics, safety and efficacy, of the proprietary DPCP ointment composition as a topical immunotherapeutic agent for the treatment of extensive alopecia areata. Up to 10 subjects w...

Efficacy and Safety of LH-8 in Paediatric Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT03240627

Nov 18th, 2019 - Methods / trial design: Randomised, double-blind, vehicle-controlled multicentre trial in parallel groups. At screening (Visit 0), subjects will discontinue their previous treatment for alopecia areata, if any. Screening period will last up to 28 ...

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT03354637

Aug 1st, 2019 - Primary: • To assess safety, tolerability and efficacy of 2 dose strengths of ATI-50002 Topical Solution, compared to vehicle in subjects with alopecia areata (AA) Secondary: • To evaluate key clinical outcome assessments

Alefacept in Patients With Severe Scalp Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT00167102

May 22nd, 2019 - Alopecia areata (AA) is an autoimmune condition characterised by a T-cell mediated attack on the hair follicle. The inciting antigenic stimulus is unknown. A dense peribulbar lymphocytic infiltrate and reproducible immunologic abnormalities are ha...

see more →

News  30 results

Pediatric Alopecia Areata in the US Has Increased Twofold Since 2009, Study Finds
https://www.medscape.com/viewarticle/954901

Jul 16th, 2021 - The prevalence of pediatric alopecia areata (AA) in the United States has increased twofold over the past decade and it disproportionately affects females and Hispanic children, according to results from the largest study to date on the topic. "Al...

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.medscape.com/viewarticle/930946

May 22nd, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.staging.medscape.com/viewarticle/930946

May 22nd, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Dermatology therapies evolve as disease knowledge and investment grow
https://www.mdedge.com/dermatology/article/219314/medical-dermatology/dermatology-therapies-evolve-disease-knowledge-and/page/0/2?channel=27980

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Pitting of fingernails
https://www.mdedge.com/familymedicine/article/215178/dermatology/pitting-fingernails?channel=203
MDedge Family Medicine;

Jan 23rd, 2020 - Given the constellation of non-scarring alopecia on the patient’s posterior scalp (with no scale, papules, or plaques), the physician diagnosed alopecia areata (AA) with associated nail pitting in this patient. Although a scalp biopsy could have c.

see more →